MTEM
Price:
$0.0001
Market Cap:
$658.00
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other target...[Read more]
Industry
Biotechnology
IPO Date
2005-02-04
Stock Exchange
OTC
Ticker
MTEM
According to Molecular Templates, Inc.’s latest financial reports and current stock price. The company's current ROE is 148.79%. This represents a change of -329.87% compared to the average of -64.73% of the last 4 quarters.
The mean historical ROE of Molecular Templates, Inc. over the last ten years is 13.12%. The current 148.79% ROE has changed 1.03% with respect to the historical average. Over the past ten years (40 quarters), MTEM's ROE was at its highest in in the December 2015 quarter at 170.67%. The ROE was at its lowest in in the September 2022 quarter at -593.40%.
Average
13.12%
Median
-42.73%
Minimum
-192.88%
Maximum
612.73%
Discovering the peaks and valleys of Molecular Templates, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.40%
Maximum Annual ROE = 612.73%
Minimum Annual Increase = -584.68%
Minimum Annual ROE = -192.88%
| Year | ROE | Change |
|---|---|---|
| 2023 | -192.88% | -131.48% |
| 2022 | 612.73% | -584.68% |
| 2021 | -126.42% | -28.50% |
| 2020 | -176.80% | 162.40% |
| 2019 | -67.38% | 124.49% |
| 2018 | -30.02% | 0.25% |
| 2017 | -29.94% | -46.01% |
| 2016 | -55.45% | -151.68% |
| 2015 | 107.29% | 19.18% |
| 2014 | 90.02% | -25.63% |
The current ROE of Molecular Templates, Inc. (MTEM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
97.81%
5-year avg
9.85%
10-year avg
13.12%
Molecular Templates, Inc.’s ROE is less than MDEChem, Inc. (0%), greater than Beleave Inc. (-341.61%), less than Arch Therapeutics, Inc. (119.36%), greater than Discover Wellness Solutions Inc. (-34.50%), less than Orchid Ventures, Inc. (210.95%), greater than IMV Inc. (-508.58%), greater than Allena Pharmaceuticals, Inc. (-160.99%), less than ACI Global Corporation (0%), greater than Micron Solutions, Inc. (-24.71%), less than EPIRUS Biopharmaceuticals, Inc. (0%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $630.00 | |
| -341.61% | $566.00 | |
| 119.36% | $444.00 | |
| -34.50% | $532.00 | |
| 210.95% | $524.00 | |
| -508.58% | $117.00 | |
| -160.99% | $122.00 | |
| 0% | $324.00 | |
| -24.71% | $317.00 | |
| 0% | $1.57K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Molecular Templates, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Molecular Templates, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Molecular Templates, Inc.'s ROE?
How is the ROE calculated for Molecular Templates, Inc. (MTEM)?
What is the highest ROE for Molecular Templates, Inc. (MTEM)?
What is the 3-year average ROE for Molecular Templates, Inc. (MTEM)?
What is the 5-year average ROE for Molecular Templates, Inc. (MTEM)?
How does the current ROE for Molecular Templates, Inc. (MTEM) compare to its historical average?